Search
forResearch 10 of 1000+
- NEW PROPRIETARY BRANDS: Gabapentin
- New drugs: Iobenguane sulfate
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW FORMULATIONS: Glatiramer acetate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →